Two mutations impair the stability and function of ubiquitin-activating enzyme (E1)

Journal of Cellular Physiology

Volumn 227, Issue 4, 2012, Pages 1561-1568

  Lao, Taotao ^a   Chen, Shuyang ^a   Sang, Nianli ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E1; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME STABILITY; MOLECULAR CLONING; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; TEMPERATURE SENSITIVITY; UBIQUITINATION; WILD TYPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BALB 3T3 CELLS; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; DNA, COMPLEMENTARY; ENZYME STABILITY; HEK293 CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; MUTATION, MISSENSE; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TEMPERATURE; TRANSFECTION; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITINATION;

EID: 84862909299     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22870     Document Type: Article

References (35)

1. Asher G, Lotem J, Sachs L, Kahana C, Shaul Y. 2002. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA 99:13125-13130.
2. Chowdary DR, Dermody JJ, Jha KK, Ozer HL. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol 14:1997-2003.
3. Ciechanover A. 2005. Intracellular protein degradation: From a vague idea, through the lysosome and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture). Angew Chem Int Ed Engl 44:5944-5967.
4. Elsasser S, Finley D. 2005. Delivery of ubiquitinated substrates to protein-unfolding machines. Nat Cell Biol 7:742-749.
5. Friedberg EC, Lehmann AR, Fuchs RP. 2005. Trading places: How do DNA polymerases switch during translesion DNA synthesis? Mol Cell 18:499-505.
6. Galan JM, Haguenauer-Tsapis R. 1997. Ubiquitin lys63 is involved in ubiquitination of a yeast plasma membrane protein. EMBO J 16:5847-5854.
7. Goldberg AL. 2007. Functions of the proteasome: From protein degradation and immune surveillance to cancer therapy. Biochem Soc Trans 35:12-17.
8. Haas AL, Rose IA. 1982. The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. J Biol Chem 257:10329-10337.
9. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67:425-479.
10. Hershko A, Heller H, Elias S, Ciechanover A. 1983. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem 258:8206-8214.
11. Hicke L. 2001. A new ticket for entry into budding vesicles-ubiquitin. Cell 106:527-530.
12. Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J. 2006. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 26:2019-2028.
13. Lake MW, Wuebbens MM, Rajagopalan KV, Schindelin H. 2001. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 414:325-329.
14. Lee I, Schindelin H. 2008. Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes. Cell 134:268-278.
15. Liang D, Kong X, Sang N. 2006. Effects of histone deacetylase inhibitors on HIF-1. Cell Cycle 5:2430-2435.
16. Lois LM, Lima CD. 2005. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J 24:439-451.
17. Mukhopadhyay D, Riezman H. 2007. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315:201-205.
18. Pickart CM, Fushman D. 2004. Polyubiquitin chains: Polymeric protein signals. Curr Opin Chem Biol 8:610-616.
19. Plans V, Guerra-Rebollo M, Thomson TM. 2008. Regulation of mitotic exit by the RNF8 ubiquitin ligase. Oncogene 27:1355-1365.
20. Rosenberg-Hasson Y, Bercovich Z, Ciechanover A, Kahana C. 1989. Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. Eur J Biochem 185:469-474.
21. Salceda S, Caro J. 1997. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642-22647.
22. Salvat C, Acquaviva C, Scheffner M, Robbins I, Piechaczyk M, Jariel-Encontre I. 2000. Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo. Eur J Biochem 267:3712-3722.
23. Schulman BA, Harper JW. 2009. Ubiquitin-like protein activation by E1 enzymes: The apex for downstream signalling pathways. Nat Rev Mol Cell Biol 10:319-331.
24. Schwartz AL, Ciechanover A. 1999. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50:57-74.
25. Semenza GL, Wang GL. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454.
26. Semenza GL, Roth PH, Fang HM, Wang GL. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757-23763.
27. Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, Nakayama K, Kitagawa M. 1999. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274:13886-13893.
28. Szczepanowski RH, Filipek R, Bochtler M. 2005. Crystal structure of a fragment of mouse ubiquitin-activating enzyme. J Biol Chem 280:22006-22011.
29. Terrell J, Shih S, Dunn R, Hicke L. 1998. A function for monoubiquitination in the internalization of a G protein-coupled receptor. Mol Cell 1:193-202.
30. Tuttle RL, Bothos J, Summers MK, Luca FC, Halazonetis TD. 2007. Defective in mitotic arrest 1/ring finger 8 is a checkpoint protein that antagonizes the human mitotic exit network. Mol Cancer Res 5:1304-1311.
31. Vassilev AP, Rasmussen HH, Christensen EI, Nielsen S, Celis JE. 1995. The levels of ubiquitinated histone H2A are highly upregulated in transformed human cells: Partial colocalization of uH2A clusters and PCNA/cyclin foci in a fraction of cells in S-phase. J Cell Sci 108:1205-1215.
32. Walden H, Podgorski MS, Schulman BA. 2003. Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. Nature 422:330-334.
33. Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones RS, Zhang Y. 2004. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431:873-878.
34. Zeng GC, Donegan J, Ozer HL, Hand R. 1984. Characterization of a ts mutant of BALB/3T3cells and correction of the defect by in vitro addition of extracts from wild-type cells. Mol Cell Biol 4:1815-1822.
35. Zeng GC, Zannis-Hadjopoulos M, Ozer HL, Hand R. 1985. Defective DNA topoisomerase I activity in a DNAts mutant of Balb/3T3cells. Somat Cell Mol Genet 11:557-569.